Cipepofol not checked
Haisco-USA Pharmaceuticals, Inc. · HSK3486
FollowEvery change as it happens, and a Monday email
Trials
2 active
17 in total · 1 in the EU
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Anesthesia, General Anesthetic
- Main trialPhase 4
- “This study is a multi-center (each center independently conducts the study according to the same research protocol), randomized, and open-label clinical study. The main objective is to verify and optimize the accuracy of the target-controlled infusion model of cipepofol.”In the company’s words, NCT06740201 on ClinicalTrials.gov
- Other names
- HSK3486 · Ciprofol
Other drugs for Anesthesia
- RamelteonNanjing Chia-tai Tianqing Pharmaceutical · Phase 3
- SolriamfetolAxsome Therapeutics, Inc. · Phase 3
- SuvorexantMerck & Co. · Phase 3
- CBD TPMAvecho Biotechnology · Phase 3
- TasimelteonVanda Pharmaceuticals · Phase 3
- HS-10506Hansoh · Phase 3
Coming up1
- May 2028Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials17
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Recruiting | 30 Mar 2025 | A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General Anesthesia During Elective Surgery | |
| Phase 3Not yet recruiting | May 2028 | HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective Surgery | |
| Phase 4Unknown | 3 Feb 2022 | Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR | |
| Phase 3Completed | 31 Dec 2020 | A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia | |
| Phase 3Completed | 2 Jun 2021 | A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical Ventilation | |
| Phase 3Completed | 29 Sep 2021 | Phase III Clinical Trial Evaluating the Efficacy and Safety of Ciprofol Injection for the Induction of Sedation/Anesthesia in Subjects Undergoing Gynecological Outpatient Surgeries | |
| Phase 3Completed | 13 Apr 2022 | Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery | |
| Phase 3Completed | 7 Nov 2023 | Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia | |
| Phase 3Completed | 23 Jul 2024 | Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery | |
| Phase 3Completed | 6 Nov 2024 | A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective Surgery | |
| Phase 2Completed | 31 May 2020 | A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation | |
| Phase 2Completed | 28 Aug 2021 | A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation | |
| Phase 1Completed | 14 Dec 2015 | A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male Subjects | |
| Phase 1Withdrawn | 1 Nov 2020 | A Study Evaluating the Mass Balance of Micro-dose[14C]HSK3486 Emulsion Injection in Healthy Adults | |
| Phase 1Completed | 3 Oct 2023 | Part 1: Dose-Finding of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users | |
| Phase 1Completed | 3 Oct 2023 | Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users | |
| Phase 1Completed | 19 May 2024 | Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026